At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BHST BIOHARVEST SCIENCES INC
Post-Mkt 10-15 19:03:37 EDT
1.70
-0.04
-2.58%
盘后1.70
+0.000.00%
16:44 EDT
High1.79Low1.53Vol12.83K
Open1.77D1 Closing1.75Amplitude14.89%
Mkt Cap38.51MTradable Cap32.84MTotal Shares22.65M
T/O21.36KT/O Rate0.07%Tradable Shares19.32M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Tate & Lyle, BioHarvest Hit Milestone in Next-Generation Sweetener Programme
Reuters  ·  10-08
Tate & Lyle, BioHarvest Hit Milestone in Next-Generation Sweetener Programme
BioHarvest Sciences Launches Share Buyback for up to 1,133,392 Shares
Reuters  ·  10-02
BioHarvest Sciences Launches Share Buyback for up to 1,133,392 Shares
BioHarvest Board Authorizes Share Buyback of up to 1,133,392 Shares Under NCIB
Reuters  ·  09-29
BioHarvest Board Authorizes Share Buyback of up to 1,133,392 Shares Under NCIB
BioHarvest Sciences Price Target Cut to $8.00/Share from $10.00 by Roth Capital
Dow Jones  ·  08-13
BioHarvest Sciences Price Target Cut to $8.00/Share from $10.00 by Roth Capital
BioHarvest Sciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary
Reuters  ·  08-12
BioHarvest Sciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary
Analysts’ Opinions Are Mixed on These Consumer Goods Stocks: BioHarvest Sciences (BHST) and Treasury Wine Estates Limited (OtherTSRYF)
TIPRANKS  ·  08-12
Analysts’ Opinions Are Mixed on These Consumer Goods Stocks: BioHarvest Sciences (BHST) and Treasury Wine Estates Limited (OtherTSRYF)
BioHarvest Sciences Rilis Presentasi Korporasi Soal Platform Kultur Sel Tanaman Untuk Produksi Senyawa Berbasis Botani
Reuters  ·  08-12
BioHarvest Sciences Rilis Presentasi Korporasi Soal Platform Kultur Sel Tanaman Untuk Produksi Senyawa Berbasis Botani
BioHarvest Q2 FY26 Net Loss Narrows to USD 3.7 Million; Revenue Rises 3.8% to USD 8.8 Million
Reuters  ·  08-11
BioHarvest Q2 FY26 Net Loss Narrows to USD 3.7 Million; Revenue Rises 3.8% to USD 8.8 Million
BioHarvest Secures Exclusive Supply Deal for 20 Tons of Rare Fragrance Product, Sees USD 20-30 Million Revenue
Reuters  ·  08-11
BioHarvest Secures Exclusive Supply Deal for 20 Tons of Rare Fragrance Product, Sees USD 20-30 Million Revenue
BioHarvest Sciences Inc. - Common Stock Q2 EPS $(0.17) Misses $(0.12) Estimate, Sales $8.837M Miss $9.537M Estimate
Benzinga Earnings  ·  08-11
BioHarvest Sciences Inc. - Common Stock Q2 EPS $(0.17) Misses $(0.12) Estimate, Sales $8.837M Miss $9.537M Estimate
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  08-11
Calendar of U.S. Earnings Expected in the Week Ahead
BioHarvest Sciences CEO Presents at Canaccord Genuity Annual Growth Conference
Reuters  ·  07-29
BioHarvest Sciences CEO Presents at Canaccord Genuity Annual Growth Conference
BioHarvest Sciences to present at BIO International Convention
Reuters  ·  06-18
BioHarvest Sciences to present at BIO International Convention
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: BioHarvest Sciences (BHST) and Brown Forman A (BF.A)
TIPRANKS  ·  06-10
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: BioHarvest Sciences (BHST) and Brown Forman A (BF.A)
Tate & Lyle expands BioHarvest collaboration on plant-based sweetener molecules
Reuters  ·  05-18
Tate & Lyle expands BioHarvest collaboration on plant-based sweetener molecules
Analysts Offer Insights on Consumer Goods Companies: Walmart (WMT) and BioHarvest Sciences (BHST)
TIPRANKS  ·  05-15
Analysts Offer Insights on Consumer Goods Companies: Walmart (WMT) and BioHarvest Sciences (BHST)
Craig-Hallum Sticks to Their Buy Rating for BioHarvest Sciences (BHST)
TIPRANKS  ·  05-15
Craig-Hallum Sticks to Their Buy Rating for BioHarvest Sciences (BHST)
BioHarvest Sciences Q1 EPS $(0.11) Beats $(0.12) Estimate, Sales $8.500M Miss $8.796M Estimate
Benzinga Earnings  ·  05-14
BioHarvest Sciences Q1 EPS $(0.11) Beats $(0.12) Estimate, Sales $8.500M Miss $8.796M Estimate
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  05-13
Calendar of U.S. Earnings Expected in the Week Ahead
Bioharvest Sciences Inc: CDMO Division Signed $1.2 Million-Dollar Stage 2 Contract
THOMSON REUTERS  ·  05-13
Bioharvest Sciences Inc: CDMO Division Signed $1.2 Million-Dollar Stage 2 Contract

Introduction

Company Name.
BIOHARVEST SCIENCES INC
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. It engages in research and development of science based therapeutic solutions for the nutraceutical industry; and plant cell-based active pharmaceutical ingredients that can assist in the treatment of specific medical indications The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Issue price:
--